1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow SARS-Associated Coronavirus: new trials by email Literature Review of SARS-Associated Coronavirus trials Research Report on SARS-Associated Coronavirus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Repurposed Approved and Under Development Therapies for Patients With Early-Onset COVID-19 and Mild Symptoms Spirulin Platensis, Budesonide Powder, Fluoxetine 20 MG - Covid19, SARS-Associated Coronavirus | Phase 3 | Unknown | Cardresearch | 7819 | 2021-01-19 | 2024-05-08 |
COVID-19 (1) · Severe Acute Respiratory Syndrome (1)
Coronaviridae Infections (1) · Coronavirus Infections (1) · Infections (1) · Lung Diseases (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Diseases (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Fluoxetine (1) · Fluvoxamine (1)
Cardresearch (1)
Brazil (1)
Edward J Mills, FRCP (1) · Gilmar Reis, MD,PhD. (1)
PMID 34717820, PMID 34927127, PMID 35353979, PMID 36516104, PMID 36780676, PMID 37068273, PMID 37256990, PMID 39232602